Stock Message Board http://investorshangout.com/search?q=MKGAY&am...mp;yt1=Go!
Last Updated: Monday, March 31, 2014 01:38:26 AM
Merck KGaA MKGAY Current Price and Quotes
Last Price
Previous Close Open
Daily Range - 52wk Range -
Volume Dividend
Average Vol (3m) Yield
Merck KGaA MKGAY
Company Information
Frankfurter Strasse 250
Darmstadt 64293
Germany
Website: http://www.merck.de/en/index.html
Phone: 49-6151-72-0
Email: investor.relations@merck.de
Merck KGaA MKGAY
Merck KGaA is a global pharmaceutical, chemical and life science company with a history that began in 1668 and a future shaped by approximately 40,000 employees in 67 countries. Merck KGaA's subsidiaries in North America operate using the umbrella brand "EMD".
Merck KGaA MKGAY
Financial Reportings and Disclosures
Reporting Status International Reporting: Frankfurt Stock Exchange
CIK 0001004059
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Germany
Year of Inc. 1827
Employees Not Available
Company Officers/Contacts
Karl-Ludwig Kle Kley CEO
Matthias Zachert CFO
Constantin Fest IR
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Merck KGaA MKGAY
MKGAY Security Details Other Company Securities
Share Structure
Market Value1 $10,944,681,140 a/o Mar 28, 2014
Shares Outstanding 64,621,120 a/o Jul 21, 2011
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.49959) Apr 24, 2013 Apr 26, 2013 May 14, 2013
Dividend (0.49079) Apr 24, 2013 Apr 26, 2013 May 14, 2013
Dividend (0.43612) Apr 18, 2012 Apr 20, 2012 May 08, 2012
Non US Stock Exchange Listing
MRK - Frankfurt Stock Exchange - Qualified
Short Selling Data
Short Interest 664 (204.59%)
Mar 14, 2014
Significant Failures to Deliver No
Transfer Agent(s)
BNY Mellon
Merck KGaA MKGAY Financials
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations
Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events
Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Merck KGaA MKGAY Recent News
Mar 27, 2014 Threshold Pharmaceuticals' Partner Merck KGaA, Darmstadt, Germany Initiates Phase 1 Dose Escalation Study of TH-302 in Combination With Gemcitabine and Nab-paclitaxel (Abraxane(R)) in Pancreatic Cancer
Mar 24, 2014 Kemira Oyj: Jari Paasikivi elected as new Chairman of the Board of Directors in the AGM, EUR 0.53 dividend approved
Mar 6, 2014 Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial and Operational Results
Feb 25, 2014 TransCelerate BioPharma Inc. Names Annalisa Jenkins as Chair of Its Board of Directors
Feb 4, 2014 ABPI, Merck KGaA, Sanofi and Many More Now Confirmed for SMi Group Big Data in Pharma Event
Jan 24, 2014 SMi Group announces inaugural Big Data in Pharma event
Dec 30, 2013 Threshold Pharmaceuticals Announces Target Enrollment of 620 Patients Achieved in Pivotal Phase 3 Trial of TH-302 in Advanced Soft Tissue Sarcoma
MKGAY Merck KGaA Research DD Guide
Stock Message Board http://investorshangout.com/search?q=MKGAY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/MKGAY/quote
Stock Chart http://www.otcmarkets.com/stock/MKGAY/chart
Company Info http://www.otcmarkets.com/stock/MKGAY/company-info
Recent News http://www.otcmarkets.com/stock/MKGAY/news
Financials http://www.otcmarkets.com/stock/MKGAY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/MKGAY/filings
Short Sales http://www.otcmarkets.com/stock/MKGAY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/MKGAY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/MKGAY/research
Summary http://finance.yahoo.com/q?s=MKGAY
Historical Prices http://finance.yahoo.com/q/hp?s=MKGAY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=MKGAY
Basic Chart http://finance.yahoo.com/q/bc?s=MKGAY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MKGAY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=MKGAY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=MKGAY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=MKGAY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=MKGAY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=MKGAY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=MKGAY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=MKGAY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=MKGAY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=MKGAY
Balance Sheet http://finance.yahoo.com/q/bs?s=MKGAY
Cash Flow http://finance.yahoo.com/q/cf?s=MKGAY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/MKGAY
Market Watch http://www.marketwatch.com/investing/stock/MKGAY
Bloomberg http://www.bloomberg.com/quote/MKGAY:US
Morningstar http://quotes.morningstar.com/stock/s?t=MKGAY
Bussinessweek http://investing.businessweek.com/research/st...cker=MKGAY
Barchart http://www.barchart.com/quotes/stocks/MKGAY
OTC Short Report http://otcshortreport.com/index.php?index=MKGAY
Investopedia http://www.investopedia.com/markets/stocks/MKGAY/?wa=0